MARC details
000 -LEADER |
fixed length control field |
04168nam a22004815i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TR-AnTOB |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085813.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220306s2022 si | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9789811672002 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-981-16-7200-2 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
TR-AnTOB |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WE 544 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJ |
Source |
bicssc |
|
Subject category code |
MED083000 |
Source |
bisacsh |
|
Subject category code |
MJ |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WE544EBK |
245 10 - TITLE STATEMENT |
Title |
Handbook of Biologics for Rheumatological Disorders |
Medium |
[electronic resource] / |
Statement of responsibility, etc. |
edited by Neeraj Jain, Lalit Duggal. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Singapore : |
Name of producer, publisher, distributor, manufacturer |
Springer Nature Singapore : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
History of Biologics -- Biologics in Rheumatoid Arthritis -- Biologics in Spondylarthritis -- Biologics in Psoriatic Arthritis -- Biologics in Gout -- Biologics in Lupus -- Biologics in Sjogren’s Syndrome -- Biologics in Systemic Sclerosis -- Biologics in Inflammatory Myopathies -- Biologics in ANCA Associated Vasculitis -- Biologics inBehcet's Syndrome -- Biologicsin Takayasu's Arteritis -- Biologics in Interstitial lung disease in Rheumatological conditions -- Biologics in Osteoporosis -- Biologics in Osteoarthritis -- Biologics in JIA -- Biologics in Paediatric CTD -- JAK inhibitors in Rheumatology -- Biologics in Rheumatic disease with Infections -- Biologics in Rheumatological conditions with Malignancy -- Biologics in Uveitis -- Biologics in Sarcoidosis -- Biologics in IgG4-RD -- Biosimilar in Rheumatology -- Off label use of Biologics in Rheumatological disorders -- Biologics & Ethical issues in Rheumatology -- Patient consent for use of biologics. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens. This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field. This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Internal medicine. |
|
Topical term or geographic name entry element |
Internal Medicine. |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Rheumatic Diseases -- therapy |
|
Uncontrolled term |
Biological Therapy |
|
Uncontrolled term |
Handbook |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Jain, Neeraj. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Duggal, Lalit. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-981-16-7200-2">https://doi.org/10.1007/978-981-16-7200-2</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |